Harvard Bioscience
HBIO
87 hedge funds and large institutions have $121M invested in Harvard Bioscience in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 38 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
39% more capital invested
Capital invested by funds: $87.3M → $121M (+$34.1M)
9% more funds holding
Funds holding: 80 → 87 (+7)
0.11% more ownership
Funds ownership: 7.37% → 7.48% (+0.11%)
42% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.48M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.22M |
| 3 |
FA
Friess Associates
Greenville,
Delaware
|
+$664K |
| 4 |
FM
Fondren Management
Houston,
Texas
|
+$544K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$453K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Algert Global
San Francisco,
California
|
-$1.08M |
| 2 |
ARM
Adirondack Research & Management
Guilderland,
New York
|
-$427K |
| 3 |
AIP
ARS Investment Partners
New York
|
-$410K |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$391K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$381K |
HBIO Hedge Fund Activity: Q1 2019 in Review
87 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q1 2019, worth a combined $121M — up 39% from $87.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new HBIO positions and 5 closed out — a net gain of 7 holders — while 22 added to existing stakes and 38 trimmed.
The largest buyer was Bank of America, adding an estimated $1.48M. The largest seller was Algert Global, cutting an estimated $1.08M.
- 87 institutional investors held Harvard Bioscience (HBIO) as of Q1 2019, up from 80 in Q4 2018.
- Funds reported $121M of Harvard Bioscience stock for Q1 2019, up 39% quarter-over-quarter.
- 12 funds opened new Harvard Bioscience positions in Q1 2019 and 5 closed out, a net change of +7 holders.
- The largest Harvard Bioscience buyer in Q1 2019 was Bank of America, an estimated $1.48M added.
- The largest Harvard Bioscience seller in Q1 2019 was Algert Global, an estimated $1.08M sold.
Based on aggregated 13F filings for Q1 2019.